MaguireKPNormaTRMcIntyreIBurrowsGD. Clinical pharmacokinetics of dothiepin. Clin Pharmacokinet1983; 8: 179–85.
2.
AdelmanMEvansESchentagJJ. Two-compartment comparison of gentamicin and tobramycin in normal volunteers. Antimicrob Agents Chemother1982; 22: 800–4.
3.
AndersenONielsenMKEriksenPBFengerMKnudsenPJ. Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations. J Pharm Sci1983; 72: 158–61.
4.
AntalEJLawsonIRAldersonLMChapronDJKramerPA. Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parameters. J Clin Psychopharmacol1982; 2: 193–8.
5.
BenetLZ. Pharmacokinetics and metabolism of bepridil. Am J Cardiol1985; 55: 8C–13C.
6.
BennettPNAaronsLJBendingMRSteinerJARowlandM. Pharmacokinetics of lidocaine and its deethylated metabolite: Dose and time dependency studies in man. J Pharmacokinet Biopharm1982; 10: 265–81.
7.
BorgstromL. Plasma levels and pharmacokinetics of cyclofenil after oral administration to man. Eur J Clin Pharmacol1981; 19: 213–6.
8.
BrazzellRKVaneFMEhmannCWColburnWA. Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur J Clin Pharmacol1983; 24: 695–702.
9.
BrosenKGramLFSchouJLarsenNEThayssenP. Dextropropoxyphene kinetics after single and repeated oral doses in man. Eur J Clin Pharmacol1985; 29: 79–84.
10.
ChanKKHSawchukRJThompsonTA. Bioequivalence of carbamazepine chewable and conventional tablets; single-dose and steady-state studies. J Pharm Sci1985; 74: 866–70.
DarraghAGordonAJO'BryneHHobbsDCaseyE. Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs. young adults. Eur J Clin Pharmacol1985; 28: 305–9.
13.
EadieMJHeazlewoodVMcKaugeLTyrerJH. Steady-state valproate pharmacokinetics during long term therapy. Clin Exp Neurol1983; 19: 183–91.
14.
EichelbaumMSomogyiA. Inter- and intra-subject variation in this first pass elimination of highly cleared drugs during chronic dosing. Eur J Clin Pharmacol1984; 26: 47–53.
15.
FaridNABergstromRFZiegeEAParliCJLembergerL. Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects. J Clin Pharmacol1985; 25: 296–301.
16.
GramLFSchmidtKChristensenFNSchouJ. D-propoxyphene kinetics in man: Significance of a deep third compartment. Eur J Clin Pharmacol1984; 26: 749–52.
17.
GreenblattDJDivollMPuriSKHoIZinnyMAShaderRI. Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation. Clin Pharmacokinet1983; 3: 83–94.
18.
HallKOttenNIrvine-MeekJ. First-dose and steady-state pharmacokinetics of valproic acid in children with seizures. Clin Pharmacokinet1983; 8: 447–55.
19.
InturrisiCEColburnWAVerebeyK. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Clin Pharmacol Ther1982; 31: 157–69.
20.
KarttunenPUusitupaMLamminsivuU. The pharmacokinetics of metformin: A comparison of the properties of a rapid-release and a sustained-release preparation. Int J Clin Pharmacol Ther Toxicol1983; 21: 31–6.
21.
KotzanJAVallnerJVStewartJTHonigbergILBrownWJ. An in vivo single- and multiple-dose study of several marketed brands of conventional and controlled-release theophylline. Drug Intell Clin Pharm1984; 18: 147–53.
22.
LagasMJonkmanJHG. Food and a sustained release theophylline tablet on chronic dosing: Bioavailability, peak-trough and trough-trough differences. Pharm Weekbl [Sci]1985; 7: 10–4.
23.
LarssonMLandahlSLundborgPRegardhCG. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol1984; 27: 217–22.
24.
MattilaJMantylaRTaskinenJMannistoP. Pharmacokinetics of sustained release verapamil after a single administration and at steady state. Eur J Drug Metab Pharmacokinet1985; 10: 133–8.
25.
MattilaJMantylaRVuorelaALamminsivuUMannistoP. Pharmacokinetics of graded oral doses of sulindac in man. Arzneimittelforschung1984; 34: 226–9.
26.
MorelandTAPriestmanDARylanceGW. Saliva carbamazepine levels in children before and during multiple dosing. Br J Clin Pharmacol1982; 13: 647–51.
27.
OchsHRGreenblattDJBodemG. Single- and multiple-dose kinetics of intravenous digoxin. Clin Pharmacol Ther1980; 28: 340–5.
RamzanMIShanksCATriggsEJ. Pharmacokinetics of tubocurarine administered by combined iv bolus and infusion. Br J Anaesth1980; 52: 893–9.
33.
RosenkranzBFischerCJakobsenPPedersenAKFrolichJC. Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state. Eur J Clin Pharmacol1983; 24: 231–5.
34.
SchulzPDickPBlaschkeTFHollisterL. Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinet1985; 10: 257–68.
35.
SchwartzJBAbernethyDRTaylorAAMitchellJR. An investigation of the cause of accumulation of verapamil during regular dosing in patients. Br J Clin Pharmacol1985; 19: 512–6.
36.
SmithRBGwiltPRWrightCE. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men. Clin Pharm1983; 2: 139–43.
37.
TaggartWVHolyoakW. Steady-state bioavailability of two sustained-released quinidine preparations: Quinidine gluconate versus quinidine sulfate. Clin Ther1983; 5: 357–64.
38.
VallnerJJKotzanJAStewartJT. Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations. Biopharm Drug Dispos1982; 3: 96–104.
39.
WagnerJGRocchiniAPVasiliadesJ. Prediction of steady-state verapamil plasma concentrations in children and adults. Clin Pharm Ther1982; 32: 172–81.
40.
WolfREberlRDunkyA. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers. J Antimicrob Chemother1984; 14 (suppl C): 63–9.
